Abby E. Alpert

Abby E. Alpert
  • Assistant Professor of Health Care Management

Contact Information

  • office Address:

    3641 Locust Walk
    303 Colonial Penn Center
    Philadelphia, PA 19104

Research Interests: health economics, public economics, pharmaceutical policy, applied econometrics

Links: CV, Personal Website

Overview

Abby Alpert is an Assistant Professor of Health Care Management at the Wharton School at the University of Pennsylvania.  She is also a faculty research fellow at the National Bureau of Economic Research.  Her research interests are in health economics and public finance. Her recent work has focused on the economics of the pharmaceutical sector.  In this area of research, she has studied Medicaid reimbursement policies, Medicaid managed care, Medicare Part D, direct-to-consumer advertising, opioid abuse, and drug shortages.  Her research has been funded by the National Institutes of Health and Agency for Healthcare Research and Quality and has been featured in media outlets including the New York Times, Washington Post, Los Angeles Times, and Vox.

Prior to joining Wharton, she was an Assistant Professor of Economics and Public Policy at The Paul Merage School of Business at the University of California in Irvine, and she was an Associate Economist at the RAND Corporation.  She received her PhD in Economics from the University of Maryland and BS in Mathematics and Economics from the University of Chicago.

Continue Reading

Teaching

Past Courses

  • HCMG215 - Management and Economics of Pharmaceutical and Biotech Industries

    This course provides an overview of the management, economic and policy issues facing the pharmaceutical and biotechnology industries. The course perspective is global, but with emphasis on the U.S. as the largest and and most profitable market. Critical issues we will examine include: R&D intensive cost structure and rapid technological change; biotech startups and alliances with the pharma industry; pricing and promotion in a complex global marketplace where customers include governments and insurers, as well as physicians, pharmacists and consumers. We use Wharton and industry experts from various disciplines to address these issues.

  • HCMG863 - Management and Economics of Pharmaceutical and Biotech Industries

    This course provides an overview of the management, economic and policy issues facing the pharmaceutical and biotechnology industries. The course perspective is global, but with emphasis on the U.S. as the largest and most profitable market. Critical issues we will examine include: R&D intensive cost structure with regulation and rapid technological change; strategic challenges of biotech startups; pricing and promotion in a complex global marketplace where customers include governments and insurers, as well as physicians and consumers; intense and evolving M&A, joint ventures, and complex alliances; government regulation of all aspects of business including market access, pricing, promotion, and manufacturing. We use Wharton and industry experts from various disciplines to address these issues.

In the News

Knowledge @ Wharton

Activity

In the News

Cause and Effect: Do Prescription Drug Ads Really Work?

Drug ads increase the number of prescriptions for medications, Wharton research finds, but that doesn't necessarily translate into health benefits.

Knowledge @ Wharton - 2017/01/4
All News